Jinyu Bio-Technology Co News
News
0
Ticker
600201.SS
ISIN
CNE000000Y37
Jinyu Bio-Technology Co Eulerpool News
Jinyu Bio-Technology Co Stock News
Jinyu Bio-Technology Co is being monitored by journalists and investors worldwide. We gather the latest Jinyu Bio-Technology Co news here.
Jinyu Bio-Technology Co Stock Press Releases
Jinyu Bio-Technology Co regularly publishes news on the company's website that are relevant for investors.
Jinyu Bio-Technology Co News 2026
This page contains all current news, analysis and press releases for Jinyu Bio-Technology Co stock (600201.SS, ISIN: CNE000000Y37). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Jinyu Bio-Technology Co.
Jinyu Bio-Technology Co Stock
Jinyu Bio-Technology Co Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas.